Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Schmidt

Showing results (61-70 of 84) with videos related to

Pageof 9
Sort By:
ACS Chemical Biology|May 15, 2012
Identification of novel inhibitors of M. tuberculosis growth using whole cell based high-throughput screeningSarah A Stanley, Sarah Schmidt Grant, Tomohiko Kawate, et al.
Bone Marrow Transplantation|April 12, 2022
Safety and feasibility of outpatient chimeric antigen receptor (CAR) T-cell therapy: experience from a tertiary care centerAzra Borogovac, Amany Keruakous, Michelle Bycko, et al.
ACS Chemical Biology|August 1, 2013
Identification of novel inhibitors of nonreplicating Mycobacterium tuberculosis using a carbon starvation modelSarah Schmidt Grant, Tomohiko Kawate, Partha P Nag, et al.
Frontiers in Oncology|November 1, 2021
Development and Characterization of a Novel Non-Lytic Cancer Immunotherapy Using a Recombinant Arenavirus Vector PlatformHenning Lauterbach, Sarah Schmidt, Kia Katchar, et al.
Journal for Immunotherapy of Cancer|April 17, 2024
Preclinical evaluation of two phylogenetically distant arenavirus vectors for the development of novel immunotherapeutic combination strategies for cancer treatmentJosipa Raguz, Catarina Pinto, Theresa Pölzlbauer, et al.
Cell Chemical Biology|June 21, 2016
Baeyer-Villiger Monooxygenases EthA and MymA Are Required for Activation of Replicating and Non-replicating Mycobacterium tuberculosis InhibitorsSarah Schmidt Grant, Samantha Wellington, Tomohiko Kawate, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|June 15, 2022
Hemodynamics of self-expanding versus balloon-expandable transcatheter heart valves in relation to native aortic annulus anatomySarah Schmidt, Vera Fortmeier, Sebastian Ludwig, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 27, 2013
Diarylcoumarins inhibit mycolic acid biosynthesis and kill Mycobacterium tuberculosis by targeting FadD32Sarah A Stanley, Tomohiko Kawate, Noriaki Iwase, et al.
The Journal of Infectious Diseases|August 21, 2023
Alternating Arenavirus Vector Immunization Generates Robust Polyfunctional Genotype Cross-Reactive Hepatitis B Virus-Specific CD8 T-Cell Responses and High Anti-Hepatitis B Surface Antigen TitersSarah Schmidt, Meron Mengistu, Stephane Daffis, et al.
NPJ Vaccines|November 9, 2023
Immunogenic arenavirus vector SIV vaccine reduces setpoint viral load in SIV-challenged rhesus monkeysArchana V Boopathy, Bhawna Sharma, Anurag Nekkalapudi, et al.
Pageof 9

Showing results (61-70 of 84) with videos related to

Sort By:
Pageof 9
ACS Chemical Biology|May 15, 2012
Identification of novel inhibitors of M. tuberculosis growth using whole cell based high-throughput screeningSarah A Stanley, Sarah Schmidt Grant, Tomohiko Kawate, et al.
Bone Marrow Transplantation|April 12, 2022
Safety and feasibility of outpatient chimeric antigen receptor (CAR) T-cell therapy: experience from a tertiary care centerAzra Borogovac, Amany Keruakous, Michelle Bycko, et al.
ACS Chemical Biology|August 1, 2013
Identification of novel inhibitors of nonreplicating Mycobacterium tuberculosis using a carbon starvation modelSarah Schmidt Grant, Tomohiko Kawate, Partha P Nag, et al.
Frontiers in Oncology|November 1, 2021
Development and Characterization of a Novel Non-Lytic Cancer Immunotherapy Using a Recombinant Arenavirus Vector PlatformHenning Lauterbach, Sarah Schmidt, Kia Katchar, et al.
Journal for Immunotherapy of Cancer|April 17, 2024
Preclinical evaluation of two phylogenetically distant arenavirus vectors for the development of novel immunotherapeutic combination strategies for cancer treatmentJosipa Raguz, Catarina Pinto, Theresa Pölzlbauer, et al.
Cell Chemical Biology|June 21, 2016
Baeyer-Villiger Monooxygenases EthA and MymA Are Required for Activation of Replicating and Non-replicating Mycobacterium tuberculosis InhibitorsSarah Schmidt Grant, Samantha Wellington, Tomohiko Kawate, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|June 15, 2022
Hemodynamics of self-expanding versus balloon-expandable transcatheter heart valves in relation to native aortic annulus anatomySarah Schmidt, Vera Fortmeier, Sebastian Ludwig, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 27, 2013
Diarylcoumarins inhibit mycolic acid biosynthesis and kill Mycobacterium tuberculosis by targeting FadD32Sarah A Stanley, Tomohiko Kawate, Noriaki Iwase, et al.
The Journal of Infectious Diseases|August 21, 2023
Alternating Arenavirus Vector Immunization Generates Robust Polyfunctional Genotype Cross-Reactive Hepatitis B Virus-Specific CD8 T-Cell Responses and High Anti-Hepatitis B Surface Antigen TitersSarah Schmidt, Meron Mengistu, Stephane Daffis, et al.
NPJ Vaccines|November 9, 2023
Immunogenic arenavirus vector SIV vaccine reduces setpoint viral load in SIV-challenged rhesus monkeysArchana V Boopathy, Bhawna Sharma, Anurag Nekkalapudi, et al.
Pageof 9